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االلتهاب الرئوي الناتج عن امليكوبالزما الرئوية مع تدهور يف االنصباب اجلنيب 
بالرغم من العالج املناسب مبضادات امليكروبات
تقرير حالة
كوثر سلمان حسن و غالب اخلضوري
abstract: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia. As M. pneumoniae 
pneumonia is usually a mild and self-limiting disease, complications such as pleural effusion occur only rarely. We 
report a 22-year-old woman who presented to the Emergency Medicine Department of the Sultan Qaboos University 
Hospital, Muscat, Oman, in 2017 with an eight-day history of fever associated with coughing, chills and rigors. She 
was diagnosed with M. pneumoniae pneumonia, but subsequently developed pleural effusion which worsened despite 
treatment with appropriate antimicrobials. The pleural effusion required drainage, which revealed that it was of the 
more severe exudative type. Following drainage, the patient improved dramatically. She was discharged and advised to 
continue taking antibiotics.
Keywords: Mycoplasma pneumoniae; Bacterial Pneumonia; Pleural Effusion; Antimicrobial Agents; Drainage; Case 
Report; Oman.
امللخ�ص: امليكوبالزما الرئوية هي �شبب �شائع لاللتهاب الرئوي املكت�شب يف املجتمع. مبا اأن اللتهاب الرئوي الناجت عن امليكوبالزما 
الرئوية هوعادة مر�ض خفيف وحمدود ذاتيًا، فاإن امل�شاعفات مثل الن�شباب اجلنبي ل حتدث اإل نادراً. نعر�ض هنا حالة امراأة تبلغ من 
العمر 22 عامًا مت اإدخالها اإىل ق�شم طب الطوارئ يف م�شت�شفى جامعة ال�شلطان قابو�ض، م�شقط، ُعمان، يف عام 2017 مع تاريخ مر�شي من 
احلمى املرتبط بال�شعال والق�شعريرة وق�شوة ملدة ثمانية اأيام. مت ت�شخي�ض اإ�شابتها بالتهاب رئوي ناجت عن امليكوبالزما الرئوية، ولكن 
اإىل تفريغ  بعد ذلك تطور اإىل الن�شباب اجلنبي الذي �شاء بالرغم من العالج مب�شادات امليكروبات املنا�شبة. احتاج الن�شباب اجلنبي 
والذي ك�شف على اأنه كان من نوع ن�شحي �شديد. بعد التفريغ، حت�شن و�شع املري�شة ب�شكل كبري. ومت ترخي�شها ون�شحت مبوا�شلة تناول 
امل�شادات احليوية.
الكلمات املفتاحية: امليكوبالزما الرئوية؛ اللتهاب الرئوي البكتريي؛ الن�شباب اجلنبي؛ م�شادات اجلراثيم؛ تفريغ؛ تقرير حالة؛ عمان.
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Mycoplasma pneumoniae are extremely small self-replicating free-living bacteria which can cause upper respiratory tract 
infections, including pharyngitis, sinusitis, ear pain, 
rhinorrhoea and pneumonia.1,2 M. pneumoniae pneu- 
monia is described as atypical and accounts for 
1–29% of community-acquired pneumonia cases.2 
The causative bacteria can be transmitted through 
aerosols as well as in settings which promote close 
physical contact, such as homes, schools, military 
barracks and dormitories.3 The post-exposure incub-
ation period is between two to three weeks and 
infections are more prevalent among children and 
young adults.4 Common risk factors include age (i.e. 
younger children or older adults), immune status 
(i.e. immunocompromised individuals with HIV or 
those undergoing chemotherapy or taking steroids), 
smoking and pre-existing lung disease.5
Classic symptoms of M. pneumoniae infection 
include fever, cough and the production of sputum; in 
most cases, the disease is self-limiting and results in a 
good prognosis.6 However, M. pneumoniae pneumonia 
can be life-threatening, resulting in respiratory failure 
or acute respiratory distress syndrome in certain cases.7 
However, pulmonary complications such as parapneu-
monic effusion are rare and occur mainly in children 
and adolescents; most cases are unilateral, low-volume 
and resolve with appropriate antimicrobial therapy.8–10 
M. pneumoniae pneumonia can be diagnosed 
by serology using an enzyme immunoassay. An acute 
infection is indicated by the detection of immuno-
globulin (Ig) A and/or IgM, with a single titre of 
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IgM greater than 1:64 or a four-fold rise in the IgG 
titre.11,12 Polymerase chain reaction (PCR) analysis 
can also be used to detect M. pneumoniae in clinical 
samples of sputum and those of nasopharyngeal and 
throat swabs. However, microbial testing is not usually 
performed for outpatients with community-acquired 
pneumonia because empirical treatment is almost 
always successful.13 This case report describes a patient 
with pneumonia who was not initially tested for 
M. pneumoniae. The patient deteriorated and developed 
severe pleural effusion, despite the administration of 
appropriate antimicrobials, necessitating drainage.
Case Report
A 22-year-old woman presented to the Emergency 
Medicine Department of the Sultan Qaboos University 
Hospital (SQUH), Muscat, Oman, in 2017 with an 
eight-day history of fever associated with coughing, 
chills and rigors. Although her coughing was initially 
dry, she had begun producing yellow-green sputum 
on day five and developed shortness of breath on day 
seven. The patient reported having recently undertaken 
a trip one week prior with her classmates, some of 
whom had also developed coughs. She was known to 
have the sickle cell trait and vitamin B12 deficiency and 
was taking weekly cyanocobalamin injections. 
Upon initial examination, the patient appeared ill, 
dehydrated, febrile and tachycardic. Her temperature 
was 40.3 ºC, her heart rate was 134 beats per minute and 
her respiratory rate was 18 breaths per minute. Pulse 
oximetry indicated an oxygen saturation of 97% in 
room air. Auscultation of the chest revealed reduced 
breath sounds in the right base. The results of initial and 
serial laboratory investigations are shown in Table 1. A 
chest X-ray showed consolidation of the right middle 
and lower lobes, with right-sided pleural effusion and 
partial lower lobe collapse [Figure 1A]. Subsequently, 
the patient was diagnosed clinically with community-
acquired pneumonia. While awaiting the results of a 
respiratory viral screening panel and sputum culture, 
she was prescribed 2 g of ceftriaxone once daily and 
500 mg of intravenous azithromycin and 75 mg of 
oseltamivir twice daily. However, the respiratory viral 
panel results were negative and the oseltamivir was 
discontinued. Three days later, the culture results of 
the sputum sample showed only upper respiratory 
commensals.
Two days after admission, the condition of the 
patient deteriorated. She was breathless at rest with a 
respiratory rate of 40 breaths per minute. Her heart 
rate had decreased to 120 beats per minute and she 
frequently vomited after episodes of coughing. A 
chest examination revealed absent breath sounds and 
Table 1: Serial blood results of the current case
Investigation Day 0 Day 2 Day 3 Day 6
Hb level in g/dL 11.9 10.9 12.6 11.1
WCC x 109/L - 6.9 7.0 8.7
ANC x 109/L - 6.9 5.7 5.8
Lp level x 109/L - 0.7 0.7 1.6
PC x 109/L - 142 157 208
Sodium level in 
mmol/L
134 137 - 140
Potassium level 
in mmol/L
3.9 3.6 - 4.0
Urea level in 
mmol/L
1.5 - 1.4 1.2
Creatinine level 
in µmol/L
59 48 - 59
Anion gap in 
mmol/L
19 16 - 14
Bicarbonate level 
in mmol/L
17 19 - 20
ALT level in U/L - - 136 33
AST level in U/L - - 118 36
Bilirubin level in 
µmol/L
- - 6 5
Hb = haemoglobin; WCC = white cell count; ANC = absolute neutro-
phil count; Lp = lipoprotein; PC = platelet count; ALT = alanine 
aminotransferase; AST = aspartate transferase.
 
Figure 1: Chest X-rays of a 22-year-old female patient with Mycoplasma pneumoniae pneumonia on (A) the day of admission 
and (B) two days later, showing worsening pleural effusion (arrow).
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stony dullness involving the middle and lower chest. 
A repeat chest X-ray confirmed that the right-sided 
pleural effusion had worsened [Figure 1B]. Accord-
ingly, a drainage procedure was performed, during 
which 2 L of exudative fluid consisting predominantly 
of lymphocytes (80%) was drained via a pigtail catheter 
over a 24-hour period. In view of her worsening 
condition, a nasopharyngeal aspirate sample was sent for 
serological and PCR testing.
The PCR test results were positive for 
M. pneumoniae, while the serology was positive for 
IgA, IgM and IgG. As the serology test was qualitative, 
exact titres were not available. Treatment was 
continued with intravenous azithromycin for five 
days, after which the patient was discharged and 
advised to take moxifloxacin for six more days. She 
made a remarkable improvement and a chest X-ray 
four weeks later showed the complete resolution of the 
pneumonic patch and pleural effusion.
Discussion
Narita et al. described two types of M. pneumoniae-
related pleural effusion with varying degrees of 
severity.14 The first is characterised by a benign transient 
chest disease, is most probably reactive as evidence of 
the M. pneumoniae genome is usually undetectable 
and has lower but still abnormal concentrations of 
interleukin (IL)-18 and IL-8. The second involves 
more persistent disease, contains M. pneumoniae 
DNA and has significantly higher IL-18 and IL-8 
concentrations.14 It is possible that the presence of 
M. pneumoniae DNA elicits a stronger immunological 
reaction, thus causing greater lung damage and higher 
concentrations of IL-8 and IL-18. In addition, two 
major strains of M. pneumoniae clinical isolates have 
been reported to differ in adhesin gene sequence.15 
Of these, type 2 is more virulent, causing respiratory 
epithelial destruction, and has a more robust biofilm, 
presumably conferring increased resistance to host 
defence mechanisms and antimicrobial penetration.15 
In the current case, although the patient was not 
tested, it is likely that she had the more severe type 
with biofilm formation, especially as she did not 
improve following antimicrobial treatment. Drainage 
of the pleural effusion might have disrupted these 
biofilms, thereby aiding the recovery process. 
Thrombocytosis can occur as a feature of 
M. pneumoniae infection and probably represents 
an acute phase response, while thrombocytopenia is 
unusual.16 Another study found that children with severe 
M. pneumoniae pneumonia had prolonged fevers, 
higher C-reactive protein levels and lower lymphocyte 
and white cell counts (WCCs).17 The patients with 
segmental/lobar pneumonia were usually older and 
had a longer fever duration and lower WCC and 
lymphocyte counts compared with those with broncho- 
pneumonia.17 M. pneumoniae infections have also been 
associated with acute chest syndrome and haemolytic 
anaemia in patients with sickle cell anaemia.18 In the 
current case, the patient did not have haemolytic 
anaemia but did have the sickle cell trait. However, no 
particular association has been reported within this 
group in terms of the severity of the infection. 
The diagnosis of an M. pneumoniae infection can 
be difficult. The Gram staining of sputum samples is 
not feasible to identify mycoplasma bacterium due to 
the absence of a cell wall; moreover, a sputum culture 
is time-consuming because of the slow growth rate of 
the pathogen in vitro.1 Enzyme-linked immunoassay-
based serology is the technique most frequently used to 
diagnose M. pneumoniae infections, although it can be 
confusing to interpret. Unfortunately, IgM antibodies 
can persist for months in some patients, thereby not 
necessarily indicating an acute infection, while others 
do not demonstrate an IgM response at all in cases of 
acute infection or reinfection.19,20 Moreover, while IgA 
is reported to be more sensitive than IgM in diagnosing 
acute infections in adults, Yamazaki et al. reported a 
lower sensitivity in young children.21,22 Therefore, the 
diagnosis of an M. pneumoniae infection relies on 
determining a four-fold increase in IgG titres taken 
two to four weeks apart.23 Spuesens et al. reported no 
obvious differences between PCR positivity rates in 
the throat swabs of individuals with suspected cases 
of M. pneumoniae infections and those of healthy 
subjects.24 This suggests that M. pneumoniae may 
colonise the upper airway without necessarily 
inducing disease. In the current case, the diagnosis of 
an M. pneumoniae infection was established by the 
IgA, IgM, IgG and PCR results of a nasopharyngeal 
swab. Furthermore, the patient’s positive response 
to azithromycin treatment following drainage of the 
pleural fluid supports this diagnosis. 
At SQUH, hospitalised patients with pneumonia 
are not routinely tested for M. pneumoniae; therefore, 
the current patient was tested only after she had 
deteriorated clinically. Nevertheless, the bacterial 
diagnosis of admitted cases of pneumonia is important, 
as patients with M. pneumoniae pneumonia require 
greater infection control measures for the duration 
of their illness, such as droplet isolation precaution 
measures.25 Although physicians tend to empirically 
treat patients requiring admission for atypical pneu-
monia, testing for M. pneumoniae pneumonia might 
also allow for the better management of pleural 
effusion cases, should further intervention be required 
beyond antimicrobial therapy.13
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Conclusion
M. pneumoniae is a common cause of community-
acquired pneumonia. Patients requiring hospital ad- 
mission should be tested for the presence of this bac-
teria, especially if they have pleural effusion.
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